 |
|
|
| |
Effect of elafibranor on pruritus in primary biliary cholangitis: Symptom severity and quality of life measurements from the phase III ELATIVE® trial
|
| |
| |
EASL 2024 | Milan, Italy | 5-8 June 2024
Andreas E. Kremer,1 Kris V. Kowdley,2 Cynthia Levy,3 Marlyn J. Mayo,4 Jörn M. Schattenberg,5 Nuno Antunes,6 Elaine A. Böing,6 Dimitar Tonev,7 Nathan Touati,7 David Jones8
|
| |
|
|
|
|
|
